Riskpilot← Back to searchSign inGet full accessSK-Medica Oy
OYDissolvedY-tunnus 2990513-7Pl 1188Medical specialists activities · NACE 8622Est. 2019— employees
Revenue 2025
EUR 2,3M
-25% vs 2024
EBITDA margin
16.0%
-31% vs 2024
Equity ratio
79.2%
Financial strength
Net profit 2025
EUR 312K
-27% vs 2024
| Revenue | EUR 2,3M | -25% |
| EBITDA | EUR 361K | -31% |
| Net profit | EUR 312K | -27% |
| Total assets | EUR 1,6M | +18% |
| Equity | EUR 1,2M | +10% |
| Employees | — | — |
Legal name
SK-Medica Oy
Y-tunnus number
2990513-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
20. maaliskuuta 2019
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Company purpose
Lääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen sekä luennointi. Yhtiö voi tuottaa lehtiartikkeleita ja asiantuntijalausuntoja. Yhtiö voi omistaa, hallita ja vuokrata sekä välittää kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Pl 1188
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 546 | 1 854 | 2 240 | 3 003 | 2 252 |
| Staff expenses | −136 | −178 | −234 | −213 | −237 |
| EBITDA | 339 | 385 | 374 | 526 | 361 |
| Depreciation & amort. | −2 | −2 | −1 | −1 | −1 |
| EBIT | 337 | 384 | 373 | 525 | 361 |
| Net financials | −0 | −25 | −4 | 9 | 29 |
| Profit before tax | 337 | 358 | 369 | 534 | 389 |
| Tax | 67 | 76 | 74 | 104 | 77 |
| Net profit | 270 | 282 | 295 | 430 | 312 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 783 | 1 142 | 1 256 | 1 319 | 1 556 |
| Equity | 752 | 974 | 890 | 1 120 | 1 232 |
| Long-term debt | — | 146 | 141 | 34 | 0 |
| Short-term debt | 31 | 22 | 225 | 166 | 324 |
| Total debt | 31 | 168 | 366 | 200 | 324 |
EBITDA margin
16.0%
This company
15.8%
Market median
+1% vs market
20212025
Equity ratio
79.2%
This company
38.2%
Market median
+107% vs market
20212025
Return on equity
25.3%
This company
18.4%
Market median
+38% vs market
20212025
Net profit margin
13.9%
This company
8.1%
Market median
+72% vs market
20212025
Asset turnover
1.45×
This company
1.12×
Market median
+29% vs market
20212025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
SE Chief Executive Officer | Chief Executive Officer | 2019 |
TM Deputy Member | Deputy Member | 2019 |
JA | Audit | 2019 |
PR Deputy auditor | Deputy auditor | 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SK-Medica Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sami Edvard Kiiskinen | Chief Executive Officer | 0 companies |
| Terhi Maria Modenius | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |